X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
3.920
+0.740 (23.27%)
At close: Aug 22, 2025, 4:00 PM
3.750
-0.170 (-4.34%)
After-hours: Aug 22, 2025, 7:59 PM EDT
X4 Pharmaceuticals Market Cap
X4 Pharmaceuticals has a market cap or net worth of $88.00 million as of August 22, 2025. Its market cap has decreased by -17.52% in one year.
Market Cap
88.00M
Enterprise Value
94.32M
1-Year Change
-17.52%
Ranking
Category
Stock Price
$3.92
Market Cap Chart
Since March 14, 2019, X4 Pharmaceuticals's market cap has decreased from $101.77M to $88.00M, a decrease of -13.53%. That is a compound annual growth rate of -2.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 71.39M | -42.94% |
| Dec 31, 2024 | 125.11M | -10.81% |
| Dec 29, 2023 | 140.27M | 16.23% |
| Dec 30, 2022 | 120.68M | 87.36% |
| Dec 31, 2021 | 64.41M | -38.49% |
| Dec 31, 2020 | 104.72M | -39.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 631.30B |
| Johnson & Johnson | 428.20B |
| AbbVie | 364.25B |
| UnitedHealth Group | 275.54B |
| AstraZeneca | 246.71B |
| Novartis AG | 242.21B |
| Novo Nordisk | 241.79B |
| Abbott Laboratories | 228.44B |